Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Biotech is a research-driven biotechnology company specializing in the development of vaccines and diagnostic tools for infectious diseases. Founded by Dr. Simon Agwale, the company maintains operations in both Nigeria and the United States, focusing on high-burden diseases such as COVID-19, Ebola, HIV, and HPV. Their core technology leverages Virus-Like Particles (VLP) to create safe and effective vaccine candidates. The company is notably committed to establishing local vaccine manufacturing infrastructure in Africa to enhance regional health security. Innovative Biotech collaborates with international academic and industrial partners to advance its pipeline through clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Biotech.